KEGG icon

Drug interaction list


Query:
D07870  Dopamine (INN); Medopa (TN)

Interactions: 50 hits    [ ATC classification | Therapeutic category ]

D00136  Haloperidol (JP18/USP/INN); Haldol (TN) (P) Target: DRD2
D00211  Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) (P) unclassified
D00331  Furosemide (JP18/USP/INN); Frusemide; Lasix (TN) (P) unclassified
D00417  Milrinone (JAN/USP/INN); Milrila (TN) (P) unclassified
D00426  Risperidone (JP18/USP/INN); Risperdal (TN) (P) Target: DRD2
D00454  Olanzapine (JAN/USP/INN); Zyprexa (TN) (P) Target: DRD2 DRD3 DRD4
D00479  Prochlorperazine maleate (JP18/USP); Compazine (TN) (P) Target: DRD2
D00503  Perphenazine (JP18/USP/INN); Trilafon (TN) (P) Target: DRD2
D00550  Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) (P) unclassified
D00781  Entacapone (JP18/USP/INN); Comtan (TN) (P) Enzyme-Target: COMT
D00789  Chlorpromazine hydrochloride (JP18/USP); Sonazine (TN) (P) Target: DRD2
D00793  Fluphenazine decanoate (JAN/USP); Prolixin decanoate (TN) (P) Target: DRD2
D00831  Mefloquine hydrochloride (JP18/USP); Lariam (TN) (P) unclassified
D01051  Spiperone (JAN/USAN); Spiropitan (TN) (P) Target: DRD2
D01101  Bromperidol (JAN/USAN/INN); Impromen (TN) (P) Target: DRD2
D01164  Aripiprazole (JAN/USP/INN); Abilify (TN) (P) Target: DRD2 DRD3
D01176  Blonanserin (JAN/INN); AD 5423 (P) Target: DRD2 DRD3
D01226  Sulpiride (JP18/USAN/INN); Dogmatyl (TN) (P) Target: DRD2
D01240  Deslanoside (JP18/USP/INN); Cedilanid-d (TN) (P) unclassified
D01321  Zotepine (JAN/INN); Setous (TN) (P) Target: DRD2
D01386  Ephedrine hydrochloride (JP18/USP); Ephedrine hydrochloride (TN) (CI) unclassified
D01482  Pipamperone hydrochloride (JAN) (P) Target: DRD2
D01485  Propericiazine (JAN); Periciazine; Neuleptil (TN) (P) Target: DRD2
D01520  Levomepromazine hydrochloride (JAN/USAN); Nozinan (TN) (P) Target: DRD2
D01522  Tiapride hydrochloride (JP18); Gramalil (TN) (P) Target: DRD2
D01548  Mosapramine hydrochloride (JAN); Cremin (TN) (P) Target: DRD2
D01697  Colforsin daropate hydrochloride (JAN); Nkh 477; Adehl (TN) (P) unclassified
D01898  Haloperidol decanoate (JAN/USP); Halomonth (TN) (P) Target: DRD2
D02022  Prochlorperazine mesilate (JAN); Prochlorperazine dimethanesulfonate; Novamin (TN) (P) Target: DRD2
D02035  Timiperone (JAN); Tolopelon (TN) (P) Target: DRD2
D02037  Perphenazine maleate (JP18); PZC (TN) (P) Target: DRD2
D02042  Olprinone hydrochloride hydrate (JAN); Coretec (TN) (P) unclassified
D02163  Fluphenazine maleate (JAN); Flumezin (TN) (P) Target: DRD2
D02208  Sultopride hydrochloride (JAN); Sultopride monohydrochloride; Barnetil (TN) (P) Target: DRD2
D02248  Levomepromazine maleate (JP18/USAN); Hirnamin (TN) (P) Target: DRD2
D02371  Clocapramine hydrochloride hydrate (JP18); Clofekton (TN) (P) Target: DRD2
D02372  Perospirone hydrochloride hydrate (JAN); Lullan (TN) (P) Target: DRD2
D02995  Asenapine maleate (JAN/USAN); Saphris (TN) (P) Target: DRD2
D04034  Chlorpromazine phenolphthalinate (JAN); Wintermin (TN) (P) Target: DRD2
D04038  Perphenazine fendizoate (JAN); PZC (TN) (P) Target: DRD2
D04338  Dihydrocodeine phosphate, ephedrine hydrochloride and ammmonium chloride; Sekicode (TN) (CI) unclassified
D04820  Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) (P) Target: DRD2
D04905  Memantine hydrochloride (JAN/USP); Namenda (TN); Memary (TN) (P) unclassified
D04965  Perphenazine hydrochloride; Perphenazine dihydrochloride; PZC intramuscular injection (TN) (P) Target: DRD2
D05339  Paliperidone (JAN/USP/INN); Invega (TN) (P) Target: DRD2
D05340  Paliperidone palmitate (JAN/USAN); Xeplion (TN); Trevicta (TN); Invega sustenna (TN); Invega trinza (TN) (P) Target: DRD2
D10293  Carbidopa, levodopa and entacapone; Stalevo (TN) (P) unclassified
D10309  Brexpiprazole (JAN/USAN/INN); Rexulti (TN) (P) Target: DRD2
D10516  Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) (P) Target: DRD2 DRD3
D10825  Opicapone (JAN/USAN/INN); Ongentys (TN) (P) Enzyme-Target: COMT